Lange Louis G insider trades
Lange Louis G has filed 10 Form 4s with the SEC that we hold, all for NewAmsterdam Pharma Co N.V. (NAMS), as Director. Across all of them we count 1 purchase worth $95.0K and 3 sales worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($2.2M). The largest single trade was a sale of 44,173 shares of NewAmsterdam Pharma Co N.V. worth $1.3M, dated 2026-03-11. The first filing on our record is dated 2024-01-03 and the latest 2026-03-12.
NewAmsterdam Pharma Co N.V. (NAMS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-02-13 | P, purchase reported on Form 4 | 5,000 | $95.0K | 2024-02-21 |
| 2026-03-06 | S, sale reported on Form 4 | 28,186 | $829.0K | 2026-03-10 |
| 2026-03-11 | S, sale reported on Form 4 | 446 | $13.9K | 2026-03-12 |
| 2026-03-11 | S, sale reported on Form 4 | 44,173 | $1.3M | 2026-03-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1238401) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms